sec.6Exemption for national blood supply arrangements— Act , s 7

sec.6 Exemption for national blood supply arrangements— Act , s 7

For section 7 (1) of the Act , each of the following activities with the following substances is prescribed— buying a listed blood product using the national blood tracking system; possessing a listed blood product obtained using the national blood tracking system; supplying, by wholesale, stock of a listed blood product using the national blood tracking system; dispensing a listed blood product on a prescription made in the national blood tracking system; giving a treatment dose of a listed blood product on a prescription made in the national blood tracking system; prescribing a listed blood product using the national blood tracking system; administering a listed blood product on a prescription made in the national blood tracking system. However, the activity is prescribed only to the extent— the activity is carried out by a person performing a function under the national blood supply arrangements; and for subsection (1) (d) or (e) —the listed blood product is labelled in compliance with— the labelling requirements stated in the Poisons Standard, Appendix L; or if the listed blood product has been granted a labelling exemption by an appropriate authority under the Poisons Standard, section 39 —any labelling requirements imposed by the appropriate authority for the product. In this section— listed blood product means an S4 medicine that is an immunoglobulin blood product mentioned on the national product price list. National Blood Agreement see the National Blood Authority Act 2003 (Cwlth) , section 3 . national blood supply arrangements means the arrangements made under the National Blood Agreement. national blood tracking system means the system for ordering, or authorising orders for, blood or blood-related products, established for facilitating the national blood supply arrangements. national product price list means the price list for blood products or blood-related products supplied under the National Blood Agreement, approved by the Ministerial Council under that agreement. s 6 amd 2023 SL No. 170 s 4 (sec.6-ssec.1) For section 7 (1) of the Act , each of the following activities with the following substances is prescribed— buying a listed blood product using the national blood tracking system; possessing a listed blood product obtained using the national blood tracking system; supplying, by wholesale, stock of a listed blood product using the national blood tracking system; dispensing a listed blood product on a prescription made in the national blood tracking system; giving a treatment dose of a listed blood product on a prescription made in the national blood tracking system; prescribing a listed blood product using the national blood tracking system; administering a listed blood product on a prescription made in the national blood tracking system. (sec.6-ssec.2) However, the activity is prescribed only to the extent— the activity is carried out by a person performing a function under the national blood supply arrangements; and for subsection (1) (d) or (e) —the listed blood product is labelled in compliance with— the labelling requirements stated in the Poisons Standard, Appendix L; or if the listed blood product has been granted a labelling exemption by an appropriate authority under the Poisons Standard, section 39 —any labelling requirements imposed by the appropriate authority for the product. (sec.6-ssec.3) In this section— listed blood product means an S4 medicine that is an immunoglobulin blood product mentioned on the national product price list. National Blood Agreement see the National Blood Authority Act 2003 (Cwlth) , section 3 . national blood supply arrangements means the arrangements made under the National Blood Agreement. national blood tracking system means the system for ordering, or authorising orders for, blood or blood-related products, established for facilitating the national blood supply arrangements. national product price list means the price list for blood products or blood-related products supplied under the National Blood Agreement, approved by the Ministerial Council under that agreement.